News Release
Thursday, May 14, 2020
Study enrolling adults with mild to moderate COVID-19 in the United States.
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial, which is being conducted by the NIAID-funded AIDS Clinical Trials Group (ACTG). Teva Pharmaceuticals is donating medications for the study.
The Phase 2b trial will enroll approximately 2,000 adults at participating ACTG sites across the United States. Study participants must have confirmed infection with SARS-CoV-2, the virus that causes COVID-19, and be experiencing fever, cough and/or shortness of breath. The investigators anticipate that many of those enrolled will be 60 years of age or older or have a comorbidity associated with developing serious complications from COVID-19, such as cardiovascular disease or diabetes. Participants will be randomly assigned to receive short-term treatment with either hydroxychloroquine and azithromycin or matching placebos. People living with HIV and pregnant and breastfeeding women also are eligible to participate in the study. The first participant enrolled today in San Diego, California.
We urgently need a safe and effective treatment for COVID-19. Repurposing existing drugs is an attractive option because these medications have undergone extensive testing, allowing them to move quickly into clinical trials and accelerating their potential approval for COVID-19 treatment, said NIAID Director Anthony S. Fauci, M.D. Although there is anecdotal evidence that hydroxychloroquine and azithromycin may benefit people with COVID-19, we need solid data from a large randomized, controlled clinical trial to determine whether this experimental treatment is safe and can improve clinical outcomes.
As of May 13, the World Health Organization (WHO) has reported 4.17 million cases of and 287,399 deaths from COVID-19 worldwide. In the United States, 1.36 million confirmed COVID-19 cases and 82,246 deaths have been reported as of May 13, according to the Centers for Disease Control and Prevention (CDC).
Currently, there are no specific therapeutics approved by the U.S. Food and Drug Administration to treat people with COVID-19. Hydroxychloroquine is FDA-approved to prevent and treat malaria, as well as to treat the autoimmune diseases rheumatoid arthritis and lupus. Some preliminary reports have suggested that hydroxychloroquine, alone or in combination with the FDA-approved antibiotic azithromycin, may benefit people with COVID-19. Numerous clinical trials are planned or underway, including a recently launched study supported by NIHs National Heart, Lung and Blood Institute evaluating the safety and effectiveness of hydroxychloroquine for treatment of adults hospitalized with COVID-19. On March 28, FDA issued an Emergency Use Authorization (EUA) to allow hydroxychloroquine and medical-grade chloroquine to be distributed from the Strategic National Stockpile and prescribed by doctors to hospitalized adolescents and adults with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Participants in the ACTG study, called A5395, will receive oral medications to take at home. Those randomly assigned to the experimental treatment group will take 400 milligrams (mg) of hydroxychloroquine twice on the first day and 200 mg twice daily for an additional six days. They also will take 500 mg of azithromycin on the first day and 250 mg daily for an additional four days. The control group will receive equivalent numbers of placebo pills. Neither the participants nor the study team will know who received experimental treatment or placebo until the end of the trial.
Participants will record their symptoms, adherence to treatment, and major events such as hospitalizations in a diary for 20 days. Study staff will follow up with participants by telephone during this period. When possible, participants will come to the clinical research site for an in-person visit at day 20. Additional follow-ups will be conducted by telephone three and six months after treatment starts.
The main objective of the study is to determine whether hydroxychloroquine and azithromycin can prevent hospitalization and death due to COVID-19. Additionally, investigators will evaluate the safety and tolerability of the experimental treatment for people with SARS-CoV-2 infection. While hydroxychloroquine and azithromycin are both considered safe in most people, they can cause side effects ranging from headache and nausea to, rarely, heart rhythm problems that can be life-threatening. Because of the risk of heart problems when hydroxychloroquine is used alone or combined with azithromycin, FDA cautions that use of hydroxychloroquine for COVID-19 should be limited to clinical trials or for treating certain hospitalized patients under EUA so clinicians can monitor patients for adverse effects.
This study will provide key data to aid responses to the COVID-19 pandemic, said ACTG Chair Judith Currier, M.D., of the University of California, Los Angeles. We are pleased to be able to leverage ACTGs existing infrastructure for HIV treatment clinical trials to quickly implement this important study.
The study team is led by Protocol Chair Davey Smith, M.D., of the University of California, San Diego. David Wohl, M.D., of the University of North Carolina at Chapel Hill, and Kara W. Chew, M.D., and Eric S. Daar, M.D., both of the University of California, Los Angeles, serve as protocol vice-chairs. The trial is expected to enroll quickly given the high incidence of COVID-19, and initial results may be available later this year.
For more information about A5395, visit ClinicalTrials.gov and search identifier NCT04358068. Adults interested in participating in the study should email actg.communications@fstrf.org.
NIAID conducts and supports researchat NIH, throughout the United States, and worldwideto study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIHTurning Discovery Into Health
###
Read the original:
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19 - National Institutes of Health
- Heart Disease - April 10th, 2018 [April 10th, 2018]
- Heart and Cardiovascular Research - April 10th, 2018 [April 10th, 2018]
- Heart and Cardiovascular Research - iMedPub - May 22nd, 2018 [May 22nd, 2018]
- Heart Disease - A Closer Look at Stem Cell Treatments - May 27th, 2018 [May 27th, 2018]
- Heart Conferences | Heart Congress | Cardiology ... - June 26th, 2018 [June 26th, 2018]
- Heart disease - Symptoms and causes - Mayo Clinic - September 21st, 2018 [September 21st, 2018]
- Diabetes, Heart Disease, and Stroke | NIDDK - September 29th, 2018 [September 29th, 2018]
- Heart Diseases & Disorders - Heart Rhythm Society - October 31st, 2018 [October 31st, 2018]
- Heart Disease - Closer Look at Stem Cells - November 15th, 2018 [November 15th, 2018]
- What is Heart Disease?, HHS, NIH, NHLBI - December 28th, 2018 [December 28th, 2018]
- Types of Heart Disease | Covenant HealthCare - December 30th, 2018 [December 30th, 2018]
- Heart Disease - Lab Tests Online - December 30th, 2018 [December 30th, 2018]
- Heart Diseases | Genetic and Rare Diseases Information Center ... - December 30th, 2018 [December 30th, 2018]
- Heart Healthy Lifestyle - Prevent Heart Diseases - HeartCare - January 26th, 2019 [January 26th, 2019]
- Breast cancer most prevalent in Sabah - The Borneo Post - October 6th, 2019 [October 6th, 2019]
- Menopause and womens heart health - Udaipur Kiran - October 6th, 2019 [October 6th, 2019]
- Low Birth Weight Linked To Heart Problems In Adulthood: Study - News Nation - October 6th, 2019 [October 6th, 2019]
- Consuming Red Meat And Pork Linked To Heart Disease And Cancer - Peoria Observer - October 6th, 2019 [October 6th, 2019]
- Yes, we still need to cut down on red and processed meat - The Conversation AU - October 6th, 2019 [October 6th, 2019]
- On oral contraceptive pills? You could be at risk of heart disease! - Times Now - October 6th, 2019 [October 6th, 2019]
- Rutgers researchers find heart valve infections increasing in hospitals - RU Daily Targum - October 6th, 2019 [October 6th, 2019]
- Most common warning symptoms of heart attack - Elets - October 6th, 2019 [October 6th, 2019]
- Adults Who Lost Teeth More Prone to Heart Attack, Stroke - SciTechDaily - October 6th, 2019 [October 6th, 2019]
- Heart and Stroke Foundation: 80% of heart attacks, strokes can be prevented - Northern Natal Courier - October 6th, 2019 [October 6th, 2019]
- Heart diseases on the rise: experts - newagebd.net - October 6th, 2019 [October 6th, 2019]
- Heart attack: Best diet to protect against the life-threatening condition - Express - October 6th, 2019 [October 6th, 2019]
- Women 'suffering and dying' because of inequalities in heart disease diagnosis and treatment - Holyrood - October 6th, 2019 [October 6th, 2019]
- B'luru's air pollution contributing to heart diseases? Study finds drivers are at risk - The News Minute - October 6th, 2019 [October 6th, 2019]
- Alia Bhatt supports fundraising for kids with heart diseases: They are more positive than adults - India Today - October 6th, 2019 [October 6th, 2019]
- Reduce heart disease at the American Heart Associations Heart Walk - KXAN.com - October 6th, 2019 [October 6th, 2019]
- Losing teeth may not be a good sign, could be indicative of heart disease risk - Economic Times - October 6th, 2019 [October 6th, 2019]
- Tooth Loss Associated with Higher Risk of Heart Disease - Cath Lab Digest - October 6th, 2019 [October 6th, 2019]
- Heart failure is the silent killer you've been ignoring - Times of India - October 10th, 2019 [October 10th, 2019]
- FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases - FDA.gov - October 10th, 2019 [October 10th, 2019]
- Daikon Radish: Types, Nutrition, Benefits, and Uses - Healthline - October 10th, 2019 [October 10th, 2019]
- Air Pollution May Affect Every Organ, Cell in the Body - Voice of America - October 10th, 2019 [October 10th, 2019]
- Less than 6 hours of sleep a night linked to increased risk of early death - NHS Website - October 10th, 2019 [October 10th, 2019]
- Disabled mum left in tears after DWP wrongly stopped all her benefits - Mirror Online - October 10th, 2019 [October 10th, 2019]
- How to live longer: Best diet to boost your life expectancy - what to eat - Express - October 10th, 2019 [October 10th, 2019]
- Men Should Stop Drinking Six Months In Advance If They Plan to Be Fathers - AskMen - October 10th, 2019 [October 10th, 2019]
- Dr. Roach: Assessing the risks of secondhand cigarette smoke - The Detroit News - October 10th, 2019 [October 10th, 2019]
- What is vascular disease? - Midland Daily News - October 10th, 2019 [October 10th, 2019]
- Fauna Bio Receives Grant From the National Institutes of Health to Advance Its Drug Repurposing Platform - BioSpace - October 10th, 2019 [October 10th, 2019]
- Bacon rashers, statistics, and controversy - The BMJ - The BMJ - October 10th, 2019 [October 10th, 2019]
- Why should you have semolina (suji) for weight loss - Times of India - October 10th, 2019 [October 10th, 2019]
- 4 blind spots in the confusing debate about red meat - Inverse - October 10th, 2019 [October 10th, 2019]
- Inflammation Signs That Are Often Overlooked - msnNOW - October 10th, 2019 [October 10th, 2019]
- MKRMS seminar: Experts stress regular exercise, healthy food for heart health - The News International - October 10th, 2019 [October 10th, 2019]
- Exercise, healthy food for heart health stressed - The News International - October 10th, 2019 [October 10th, 2019]
- AstraZeneca HealthCare Foundation Awards $775000 to 11 Innovative Heart Health Programs & Announces Open Call for Applications - Business Wire - October 10th, 2019 [October 10th, 2019]
- How to live longer: The superfood proven to boost brain and heart health - Express - October 10th, 2019 [October 10th, 2019]
- People with mental disorder at high risk of heart diseases - Yahoo India News - October 10th, 2019 [October 10th, 2019]
- Do Women Need To Worry About Heart Disease? - Version Weekly - October 10th, 2019 [October 10th, 2019]
- Stroke rates continue decline in the U.S. - Reuters - October 10th, 2019 [October 10th, 2019]
- 6 Foods That Can Help Protect You Against Life-Threatening Ailments - International Business Times - October 10th, 2019 [October 10th, 2019]
- Prevention of Heart Disease - The Sentinel Assam - October 10th, 2019 [October 10th, 2019]
- Tooth loss linked to higher risk of heart disease - The New Indian Express - October 10th, 2019 [October 10th, 2019]
- Performing HIIT Exercises Can Help Minimize The Risk Of Contracting A Heart Disease - International Business Times - October 10th, 2019 [October 10th, 2019]
- Heart disease: Best exercise to lower the risk of developing the deadly condition - Express - October 10th, 2019 [October 10th, 2019]
- Shropshire people left more than 343000 in wills to British Heart Foundation - shropshirestar.com - October 11th, 2019 [October 11th, 2019]
- Queen's Speech puts air pollution, science and the NHS on the agenda - British Heart Foundation - October 15th, 2019 [October 15th, 2019]
- In a rural Wisconsin village, the doctor makes house calls and sees some of the rarest diseases on Earth - Milwaukee Journal Sentinel - October 15th, 2019 [October 15th, 2019]
- Treatment And Management Of Heart Disease During Pregnancy - Version Weekly - October 15th, 2019 [October 15th, 2019]
- Severe dental diseases persist in S.D. due to chronic poverty and lack of access to dentists - KELO AM-FM - October 15th, 2019 [October 15th, 2019]
- New York Ranks 25th In Nation In First-Ever Childhood Obesity Study - WAER - October 15th, 2019 [October 15th, 2019]
- Saddleridge Fire Leads to Poor Air Quality, Tips on Staying Healthy - NBC Southern California - October 15th, 2019 [October 15th, 2019]
- This country just became the first to ban ads for sugary drinks - WGAL Lancaster - October 15th, 2019 [October 15th, 2019]
- Heart disease: Three dietary tips to keep the risks at bay - Express - October 15th, 2019 [October 15th, 2019]
- Eating habits that can reverse heart disease - Daily Monitor - October 15th, 2019 [October 15th, 2019]
- Hale and hearty: Tips to maintain good heart health - The New Indian Express - October 15th, 2019 [October 15th, 2019]
- Exercise Is Especially Important For Those With Heart Disease - Anti Aging News - October 15th, 2019 [October 15th, 2019]
- Exercise good for people with heart disease, other physical ailments - Al Bawaba - October 15th, 2019 [October 15th, 2019]
- Should you eat red meat or not? A dietitian explains the latest nutrition science on meat, eggs and butter - NBC News - October 15th, 2019 [October 15th, 2019]
- Rheumatic heart disease in Northern Territory 'a bloody health emergency' - The Guardian - October 15th, 2019 [October 15th, 2019]
- PPMD Grants to Promote Gene Therapy for Heart Disease and Patient Outcomes Research - Muscular Dystrophy News - October 15th, 2019 [October 15th, 2019]
- University of Guelph researchers track how cats' weights change over time - Jill Lopez - October 20th, 2019 [October 20th, 2019]
- Study Shows That a 50% Pay Raise Lowers the Risk of Cardiovascular Diseases by 15% - WORLD OF BUZZ - October 20th, 2019 [October 20th, 2019]
- Dog owners less likely to have cardiovascular diseases, and better chances of recovering from strokes or heart - MEAWW - October 20th, 2019 [October 20th, 2019]
- Keep your heart pumping - The New Indian Express - October 20th, 2019 [October 20th, 2019]
- How Can We Curb the Spread of Scientific Racism? - Scientific American - October 20th, 2019 [October 20th, 2019]